The Europe surgical suture market is expected to witness significant growth during the forecast period due to the rise in the number of cardiovascular surgeries and general surgeries across the globe. Thus, in Europe the conditions and symptoms such as rise in diabetic cases and lifestyle changes are leading to increasing number of cardiovascular surgeries and general surgeries. Since the last 25 years, the number of cardiovascular cases has increased in the European countries. As per the European Cardiovascular Disease Statistics in 2015, about 85 million people in Europe and 49 million in EU were suffering with cardiovascular diseases.
The UK is one of the key markets for surgical suture in Europe. As per the British Heart Foundation (BHF) statistics there are nearly 7 million people suffering from cardiovascular diseases in the UK, especially the aging population. Analyzing the facts for the cardiovascular disease, BHF conducted innovative health programs to improve services for people living with CVD or at risk of CVD.
Furthermore, the National Health Service (NHS) in England has a scheme that will help patients get benefited with the innovative products. For instance, an innovative and surgical suture that aims to reduce the risk of infection from Methicillin-resistant Staphylococcus aureus (MRSA), which causes serious skin infections or infect surgical wounds, will join the NHS schemes.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 925.29 Million |
Market Size by 2027 | US$ 1,413.74 Million |
Global CAGR (2020 - 2027) | 5.6% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
The List of Companies - Europe Surgical Suture Market